{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:15:36Z","timestamp":1775830536195,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81502016"],"award-info":[{"award-number":["81502016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00296-021-04978-1","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T13:03:46Z","timestamp":1631192626000},"page":"149-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3142-1732","authenticated-orcid":false,"given":"Xia","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4825-5227","authenticated-orcid":false,"given":"Qiong-yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8052-0828","authenticated-orcid":false,"given":"Mengyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1507-8540","authenticated-orcid":false,"given":"Jinchao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1016-9064","authenticated-orcid":false,"given":"Jialin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2682-3542","authenticated-orcid":false,"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1243-5170","authenticated-orcid":false,"given":"Xiaobing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2823-4349","authenticated-orcid":false,"given":"Junna","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0358-8933","authenticated-orcid":false,"given":"Yutong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3574-8807","authenticated-orcid":false,"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9587-1180","authenticated-orcid":false,"given":"Huihui","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1109-5781","authenticated-orcid":false,"given":"Zhuochao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6043-3340","authenticated-orcid":false,"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-1408","authenticated-orcid":false,"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9529-6603","authenticated-orcid":false,"given":"Liyan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0866-5974","authenticated-orcid":false,"given":"Xin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6585-9711","authenticated-orcid":false,"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0565-2393","authenticated-orcid":false,"given":"Xinyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3720-634X","authenticated-orcid":false,"given":"Chengde","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-0373","authenticated-orcid":false,"given":"Hong-Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"issue":"7","key":"4978_CR1","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J (2014) Adult-onset Still\u2019s disease. Autoimmun Rev 13(7):708\u2013722. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.058","journal-title":"Autoimmun Rev"},{"issue":"5","key":"4978_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","volume":"22","author":"B Fautrel","year":"2008","unstructured":"Fautrel B (2008) Adult-onset Still disease. Best Pract Res Clin Rheumatol 22(5):773\u2013792. https:\/\/doi.org\/10.1016\/j.berh.2008.08.006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"4978_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist E, Mitrovic S, Fautrel B (2018) Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol 14(10):603\u2013618. https:\/\/doi.org\/10.1038\/s41584-018-0081-x","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"4978_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/art.1780290316","volume":"29","author":"JM Wouters","year":"1986","unstructured":"Wouters JM, Reekers P, van de Putte LB (1986) Adult-onset Still\u2019s disease. Disease course and HLA associations. Arthritis Rheum 29(3):415\u2013418. https:\/\/doi.org\/10.1002\/art.1780290316","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4978_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/art.1780280207","volume":"28","author":"ML Miller","year":"1985","unstructured":"Miller ML, Aaron S, Jackson J, Fraser P, Cairns L, Hoch S, Borel Y, Larson M, Glass DN (1985) HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 28(2):146\u2013150. https:\/\/doi.org\/10.1002\/art.1780280207","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4978_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13075-017-1406-x","volume":"19","author":"T Asano","year":"2017","unstructured":"Asano T, Furukawa H, Sato S, Yashiro M, Kobayashi H, Watanabe H, Suzuki E, Ito T, Ubara Y, Kobayashi D, Iwanaga N, Izumi Y, Fujikawa K, Yamasaki S, Nakamura T, Koga T, Shimizu T, Umeda M, Nonaka F, Yasunami M, Ueki Y, Eguchi K, Tsuchiya N, Tohma S, Yoshiura KI, Ohira H, Kawakami A, Migita K (2017) Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still\u2019s disease. Arthritis Res Ther 19(1):199. https:\/\/doi.org\/10.1186\/s13075-017-1406-x","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"4978_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/14397595.2018.1514999","volume":"29","author":"Y Fujita","year":"2019","unstructured":"Fujita Y, Furukawa H, Asano T, Sato S, Yashiro Furuya M, Kobayashi H, Watanabe H, Suzuki E, Koga T, Shimizu T, Ueki Y, Eguchi K, Tsuchiya N, Kawakami A, Migita K (2019) HLA-DQB1 DPB1 alleles in Japanese patients with adult-onset Still\u2019s disease. Mod Rheumatol 29(5):843\u2013847. https:\/\/doi.org\/10.1080\/14397595.2018.1514999","journal-title":"Mod Rheumatol"},{"issue":"1","key":"4978_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/annrheumdis-2019-215239","volume":"79","author":"ZQ Li","year":"2020","unstructured":"Li ZQ, Liu HL, Chen JH, Zeng T, He L, Li MH, Luo CN, Liu S, Ding TT, Yimaiti K, Teng JL, Li XW, Ding YH, Cheng XB, Zhou J, Ye JN, Ji J, Su YT, Shi H, Sun Y, Gao CW, Hu QY, Chi HH, Yuan X, Zhou ZC, Wang D, Wang K, Li CG, Sun YC, Niu YJ, Chen LJ, Xu J, Wu LJ, Zhou ZW, Pan D, Niu HT, Shi YY, Yang CD (2020) Both HLA class I and II regions identified as genome-wide significant susceptibility loci for adult-onset Still\u2019s disease in Chinese individuals. Ann Rheum Dis 79(1):161. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215239","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"4978_CR9","doi-asserted-by":"publisher","first-page":"7760","DOI":"10.3390\/ijms22147760","volume":"22","author":"GA Secker","year":"2021","unstructured":"Secker GA, Harvey NL (2021) Regulation of VEGFR signalling in lymphatic vascular development and disease: an update. Int J Mol Sci 22(14):7760. https:\/\/doi.org\/10.3390\/ijms22147760","journal-title":"Int J Mol Sci"},{"key":"4978_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674343","volume":"12","author":"H Zhan","year":"2021","unstructured":"Zhan H, Li H, Liu C, Cheng L, Yan S, Li Y (2021) Association of Circulating Vascular Endothelial Growth Factor Levels with Autoimmune Diseases: a systematic review and meta-analysis. Front Immunol 12:674343. https:\/\/doi.org\/10.3389\/fimmu.2021.674343","journal-title":"Front Immunol"},{"issue":"2","key":"4978_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.gene.2015.01.023","volume":"558","author":"HK Chen","year":"2015","unstructured":"Chen HK, Zhang TY, Gong BL, Cao XH (2015) Association between VEGF-634G\/C polymorphism and susceptibility to autoimmune diseases: a meta-analysis. Gene 558(2):181\u2013186. https:\/\/doi.org\/10.1016\/j.gene.2015.01.023","journal-title":"Gene"},{"issue":"5","key":"4978_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41419-018-0570-5","volume":"9","author":"W Jia","year":"2018","unstructured":"Jia W, Wu W, Yang D, Xiao C, Huang M, Long F, Su Z, Qin M, Liu X, Zhu YZ (2018) GATA4 regulates angiogenesis and persistence of inflammation in rheumatoid arthritis. Cell Death Dis 9(5):503. https:\/\/doi.org\/10.1038\/s41419-018-0570-5","journal-title":"Cell Death Dis"},{"key":"4978_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114702","volume":"380","author":"AE Abdel-Maged","year":"2019","unstructured":"Abdel-Maged AE, Gad AM, Wahdan SA, Azab SS (2019) Efficacy and safety of Ramucirumab and methotrexate co-therapy in rheumatoid arthritis experimental model: Involvement of angiogenic and immunomodulatory signaling. Toxicol Appl Pharmacol 380:114702. https:\/\/doi.org\/10.1016\/j.taap.2019.114702","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"4978_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/(sici)1097-0215(20000401)86:1<47::aid-ijc7>3.0.co;2-r","volume":"86","author":"S Shushanov","year":"2000","unstructured":"Shushanov S, Bronstein M, Adelaide J, Jussila L, Tchipysheva T, Jacquemier J, Stavrovskaya A, Birnbaum D, Karamysheva A (2000) VEGFc and VEGFR3 expression in human thyroid pathologies. Int J Cancer 86(1):47\u201352. https:\/\/doi.org\/10.1002\/(sici)1097-0215(20000401)86:1%3c47::aid-ijc7%3e3.0.co;2-r","journal-title":"Int J Cancer"},{"issue":"10","key":"4978_CR15","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/ard.2008.094664","volume":"68","author":"P Kumpers","year":"2009","unstructured":"Kumpers P, David S, Haubitz M, Hellpap J, Horn R, Brocker V, Schiffer M, Haller H, Witte T (2009) The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus. Ann Rheum Dis 68(10):1638\u20131643. https:\/\/doi.org\/10.1136\/ard.2008.094664","journal-title":"Ann Rheum Dis"},{"key":"4978_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.intimp.2019.05.024","volume":"73","author":"Y Li","year":"2019","unstructured":"Li Y, Yang B, Bai JY, Xia S, Mao M, Li X, Li N, Chen L (2019) The roles of synovial hyperplasia, angiogenesis and osteoclastogenesis in the protective effect of apigenin on collagen-induced arthritis. Int Immunopharmacol 73:362\u2013369. https:\/\/doi.org\/10.1016\/j.intimp.2019.05.024","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"4978_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/08916934.2020.1755965","volume":"53","author":"CW Cheng","year":"2020","unstructured":"Cheng CW, Wu CZ, Tang KT, Fang WF, Lin JD (2020) Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases. Autoimmunity 53(5):261\u2013269. https:\/\/doi.org\/10.1080\/08916934.2020.1755965","journal-title":"Autoimmunity"},{"issue":"3","key":"4978_CR18","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T et al (1992) Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol 19(3):424\u2013430","journal-title":"J Rheumatol"},{"issue":"11","key":"4978_CR19","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3899\/jrheum.100247","volume":"37","author":"M Rau","year":"2010","unstructured":"Rau M, Schiller M, Krienke S, Heyder P, Lorenz H, Blank N (2010) Clinical manifestations but not cytokine profiles differentiate adult-onset Still\u2019s disease and sepsis. J Rheumatol 37(11):2369\u20132376. https:\/\/doi.org\/10.3899\/jrheum.100247","journal-title":"J Rheumatol"},{"issue":"12","key":"4978_CR20","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","volume":"55","author":"C Girard","year":"2016","unstructured":"Girard C, Rech J, Brown M, Allali D, Roux-Lombard P, Spertini F, Schiffrin EJ, Schett G, Manger B, Bas S, Del Val G, Gabay C (2016) Elevated serum levels of free interleukin-18 in adult-onset Still\u2019s disease. Rheumatology 55(12):2237\u20132247. https:\/\/doi.org\/10.1093\/rheumatology\/kew300","journal-title":"Rheumatology"},{"key":"4978_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab023","author":"J Meng","year":"2021","unstructured":"Meng J, Chi H, Wang Z, Zhang H, Sun Y, Teng J, Hu Q, Liu H, Cheng X, Ye J, Shi H, Wu X, Jia J, Wang M, Ma Y, Zhou Z, Wang F, Liu T, Wan L, Qiao X, Chen X, Yang C, Su Y (2021) Characteristics and risk factors of relapses in patients with adult-onset still\u2019s disease: a long-term cohort study. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keab023","journal-title":"Rheumatology"},{"issue":"5","key":"4978_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1089\/bio.2015.0104","volume":"14","author":"HW Grievink","year":"2016","unstructured":"Grievink HW, Luisman T, Kluft C, Moerland M, Malone KE (2016) Comparison of Three Isolation Techniques for Human Peripheral Blood Mononuclear Cells: Cell Recovery and Viability, Population Composition, and Cell Functionality. Biopreserv Biobank 14(5):410\u2013415. https:\/\/doi.org\/10.1089\/bio.2015.0104","journal-title":"Biopreserv Biobank"},{"issue":"5","key":"4978_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1399-0039.2008.01134.x","volume":"72","author":"J Wongpiyabovorn","year":"2008","unstructured":"Wongpiyabovorn J, Yooyongsatit S, Ruchusatsawat K, Avihingsanon Y, Hirankarn N (2008) Association of the CTG (-2578\/-460\/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis. Tissue Antigens 72(5):458\u2013463. https:\/\/doi.org\/10.1111\/j.1399-0039.2008.01134.x","journal-title":"Tissue Antigens"},{"issue":"7","key":"4978_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/sj.gene.6363922","volume":"3","author":"T Sugiura","year":"2002","unstructured":"Sugiura T, Kawaguchi Y, Harigai M, Terajima-Ichida H, Kitamura Y, Furuya T, Ichikawa N, Kotake S, Tanaka M, Hara M, Kamatani N (2002) Association between adult-onset Still\u2019s disease and interleukin-18 gene polymorphisms. Genes Immun 3(7):394\u2013399. https:\/\/doi.org\/10.1038\/sj.gene.6363922","journal-title":"Genes Immun"},{"issue":"7","key":"4978_CR25","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/1529-0131(200107)44:7<1716::Aid-Art298>3.0.Co;2-I","volume":"44","author":"Y Kawaguchi","year":"2001","unstructured":"Kawaguchi Y, Terajima H, Harigai M, Hara M, Kamatani N (2001) Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still\u2019s disease. Arthritis Rheum 44(7):1716\u20131717. https:\/\/doi.org\/10.1002\/1529-0131(200107)44:7%3c1716::Aid-Art298%3e3.0.Co;2-I","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4978_CR26","first-page":"396","volume":"25","author":"T Hoshino","year":"1998","unstructured":"Hoshino T, Ohta A, Yang D, Kawamoto M, Kikuchi M, Inoue Y, Kamizono S, Ota T, Itoh K, Oizumi K (1998) Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still\u2019s disease. J Rheumatol 25(2):396\u2013398","journal-title":"J Rheumatol"},{"issue":"10","key":"4978_CR27","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/ard.2003.013680","volume":"63","author":"DY Chen","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC (2004) Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still\u2019s disease. Ann Rheum Dis 63(10):1300\u20131306. https:\/\/doi.org\/10.1136\/ard.2003.013680","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4978_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13075-020-02200-4","volume":"22","author":"T Koga","year":"2020","unstructured":"Koga T, Sumiyoshi R, Furukawa K, Sato S, Migita K, Shimizu T, Umeda M, Endo Y, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Nonaka F, Yachie A, Kondo H, Maeda T, Kawakami A (2020) Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still\u2019s disease from sepsis. Arthritis Res Ther 22(1):108. https:\/\/doi.org\/10.1186\/s13075-020-02200-4","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"4978_CR29","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3390\/ijms19072012","volume":"19","author":"IJ MacDonald","year":"2018","unstructured":"MacDonald IJ, Liu SC, Su CM, Wang YH, Tsai CH, Tang CH (2018) Implications of angiogenesis involvement in arthritis. Int J Mol Sci 19(7):2012. https:\/\/doi.org\/10.3390\/ijms19072012","journal-title":"Int J Mol Sci"},{"issue":"1\u20133","key":"4978_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.febslet.2004.08.036","volume":"575","author":"M Osada","year":"2004","unstructured":"Osada M, Imaoka S, Funae Y (2004) Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein. FEBS Lett 575(1\u20133):59\u201363. https:\/\/doi.org\/10.1016\/j.febslet.2004.08.036","journal-title":"FEBS Lett"},{"issue":"1","key":"4978_CR31","first-page":"34","volume":"29","author":"K Wauke","year":"2002","unstructured":"Wauke K, Nagashima M, Ishiwata T, Asano G, Yoshino S (2002) Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue. J Rheumatol 29(1):34\u201338","journal-title":"J Rheumatol"},{"issue":"1","key":"4978_CR32","first-page":"39","volume":"29","author":"K Paavonen","year":"2002","unstructured":"Paavonen K, Mandelin J, Partanen T, Jussila L, Li TF, Ristimaki A, Alitalo K, Konttinen YT (2002) Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J Rheumatol 29(1):39\u201345","journal-title":"J Rheumatol"},{"issue":"1","key":"4978_CR33","first-page":"16","volume":"34","author":"HS Cha","year":"2007","unstructured":"Cha HS, Bae EK, Koh JH, Chai JY, Jeon CH, Ahn KS, Kim J, Koh EM (2007) Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes. J Rheumatol 34(1):16\u201319","journal-title":"J Rheumatol"},{"issue":"2","key":"4978_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrrheum.2017.205","volume":"14","author":"EM Bouta","year":"2018","unstructured":"Bouta EM, Bell RD, Rahimi H, Xing LP, Wood RW, Bingham CO, Ritchlin CT, Schwarz EM (2018) Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis. Nat Rev Rheumatol 14(2):94\u2013106. https:\/\/doi.org\/10.1038\/nrrheum.2017.205","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"4978_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","volume":"32","author":"A Palazon","year":"2017","unstructured":"Palazon A, Tyrakis PA, Macias D, Velica P, Rundqvist H, Fitzpatrick S, Vojnovic N, Phan AT, Loman N, Hedenfalk I, Hatschek T, Lovrot J, Foukakis T, Goldrath AW, Bergh J, Johnson RS (2017) An HIF-1alpha\/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression. Cancer Cell 32(5):669-683.e665. https:\/\/doi.org\/10.1016\/j.ccell.2017.10.003","journal-title":"Cancer Cell"},{"issue":"6","key":"4978_CR36","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1084\/jem.172.6.1535","volume":"172","author":"M Clauss","year":"1990","unstructured":"Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D (1990) Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172(6):1535\u20131545. https:\/\/doi.org\/10.1084\/jem.172.6.1535","journal-title":"J Exp Med"},{"issue":"6","key":"4978_CR37","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669\u2013676. https:\/\/doi.org\/10.1038\/nm0603-669","journal-title":"Nat Med"},{"issue":"1","key":"4978_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","volume":"18","author":"N Ferrara","year":"1997","unstructured":"Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18(1):4\u201325. https:\/\/doi.org\/10.1210\/edrv.18.1.0287","journal-title":"Endocr Rev"},{"issue":"2","key":"4978_CR39","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1074\/jbc.271.2.736","volume":"271","author":"T Cohen","year":"1996","unstructured":"Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271(2):736\u2013741. https:\/\/doi.org\/10.1074\/jbc.271.2.736","journal-title":"J Biol Chem"},{"issue":"1","key":"4978_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.0022-202X.2004.22735.x","volume":"123","author":"YW Kwon","year":"2004","unstructured":"Kwon YW, Kwon KS, Moon HE, Park JA, Choi KS, Kim YS, Jang HS, Oh CK, Lee YM, Kwon YG, Lee YS, Kim KW (2004) Insulin-like growth factor-II regulates the expression of vascular endothelial growth factor by the human keratinocyte cell line HaCaT. J Invest Dermatol 123(1):152\u2013158. https:\/\/doi.org\/10.1111\/j.0022-202X.2004.22735.x","journal-title":"J Invest Dermatol"},{"issue":"9","key":"4978_CR41","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.intimp.2005.04.002","volume":"5","author":"L Malaguarnera","year":"2005","unstructured":"Malaguarnera L, Imbesi R, Di Rosa M, Scuto A, Castrogiovanni P, Messina A, Sanfilippo S (2005) Action of prolactin, IFN-gamma, TNF-alpha and LPS on heme oxygenase-1 expression and VEGF release in human monocytes\/macrophages. Int Immunopharmacol 5(9):1458\u20131469. https:\/\/doi.org\/10.1016\/j.intimp.2005.04.002","journal-title":"Int Immunopharmacol"},{"issue":"5\u20136","key":"4978_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/s0736-5748(99)00048-9","volume":"17","author":"MM Valter","year":"1999","unstructured":"Valter MM, Wiestler OD, Pietsche T (1999) Differential control of VEGF synthesis and secretion in human glioma cells by IL-1 and EGF. Int J Dev Neurosci 17(5\u20136):565\u2013577. https:\/\/doi.org\/10.1016\/s0736-5748(99)00048-9","journal-title":"Int J Dev Neurosci"},{"issue":"2","key":"4978_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab F, Mayer-Barber K, Sher A, Wack A, O\u2019Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15(2):87\u2013103. https:\/\/doi.org\/10.1038\/nri3787","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4978_CR44","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.chom.2016.05.016","volume":"19","author":"GM Boxx","year":"2016","unstructured":"Boxx GM, Cheng G (2016) The Roles of Type I Interferon in Bacterial Infection. Cell Host Microbe 19(6):760\u2013769. https:\/\/doi.org\/10.1016\/j.chom.2016.05.016","journal-title":"Cell Host Microbe"},{"issue":"1","key":"4978_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrrheum.2009.237","volume":"6","author":"JC Hall","year":"2010","unstructured":"Hall JC, Rosen A (2010) Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol 6(1):40\u201349. https:\/\/doi.org\/10.1038\/nrrheum.2009.237","journal-title":"Nat Rev Rheumatol"},{"key":"4978_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","volume":"67","author":"M Postal","year":"2020","unstructured":"Postal M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, Appenzeller S, Niewold TB (2020) Type I interferon in the pathogenesis of systemic lupus erythematosus. Curr Opin Immunol 67:87\u201394. https:\/\/doi.org\/10.1016\/j.coi.2020.10.014","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"4978_CR47","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1084\/jem.20180861","volume":"216","author":"F Ning","year":"2019","unstructured":"Ning F, Li X, Yu L, Zhang B, Zhao Y, Liu Y, Zhao B, Shang Y, Hu X (2019) Hes1 attenuates type I IFN responses via VEGF-C and WDFY1. J Exp Med 216(6):1396\u20131410. https:\/\/doi.org\/10.1084\/jem.20180861","journal-title":"J Exp Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04978-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04978-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04978-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T13:03:58Z","timestamp":1643893438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04978-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4978"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04978-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"16 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved by the Institutional Research Ethics Committee of Ruijin Hospital (identifier 2016\u201362), Shanghai, China. The patients\/participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}